In Massachusetts, GenePeeks, Inc. has a new President and Chief Commercial Officer, Matt Posard, who comes with over 25 years of experience at a variety of genomic and life sciences companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. His role at GenePeeks will be to head up commercialization of their computational genomics products and services. Their patented Virtual Progeny Analytics product takes the genetic makeup of two parents and computationally predicts what diseases or health issues their child will be at risk for, genetically speaking, before they even conceive a baby. Many parents want to know the risks before they conceive, especially for serious diseases, so they can be more prepared for the possibilities.
Latest article
Not PLA‑ying dead: Bioplastic skulls replace gory antler mounts
In Utah, Bucks N Bull Skulls is using bioplastic polylactic acid filament to 3-D print animal skulls for mounting antlers – an alternative that...
Funding flatlines: Meatable closes up shop
In the Netherlands, cultivated meat pioneer Meatable has failed to secure sufficient funding and is winding down operations. The company had been operating a...
“Sound” investment: Biobased acoustic panel maker Aisti receives €20 million EIB loan
In Finland, sustainable acoustics products firm Aisti has received a €20 million (US$23.4 million) loan from the European Investment Bank to scale production of...